Literature DB >> 7610054

Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.

J D Thompson1, D F Ayers, T A Malmstrom, T L McKenzie, L Ganousis, B M Chowrira, L Couture, D T Stinchcomb.   

Abstract

RNA polymerase III (pol III) transcripts are abundant in all cells. Therefore, pol III promoters may be ideal for expressing high levels of exogenous RNAs, such as antisense RNAs, decoy RNAs and ribozymes, in many different cell types. We have improved accumulation of recombinant RNAs expressed from a human meti tRNA-derived pol III promoter > 100-fold by modifying the 3' terminus of the transcripts to hybridize to the 5' terminus. This terminal duplex includes the 8 nt leader sequence present in the primary wild-type meti tRNA transcript that is normally removed during processing to the mature tRNA. Expression of an anti-HIV ribozyme was analyzed in cells stably transduced with retroviral vectors encoding pol III transcription units containing this modification. High accumulation of recombinant pol III ribozyme transcripts was observed in all cell lines tested. Due to the enhanced transcript accumulation, ribozyme cleavage activity was readily detectable in total RNA extracted from stably transduced human T cell lines. One pol III transcription unit, termed 'TRZ', was optimized further for ribozyme cleavage activity. The improved pol III transcription units reported here may be useful for expressing a variety of functional and therapeutic RNAs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610054      PMCID: PMC307016          DOI: 10.1093/nar/23.12.2259

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.

Authors:  B A Sullenger; H F Gallardo; G E Ungers; E Gilboa
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

2.  Ribozyme-mediated cleavage of an HIV-1 gag RNA: the effects of nontargeted sequences and secondary structure on ribozyme cleavage activity.

Authors:  N R Taylor; J J Rossi
Journal:  Antisense Res Dev       Date:  1991

3.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin.

Authors:  L C Bock; L C Griffin; J A Latham; E H Vermaas; J J Toole
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

4.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

5.  Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

Authors:  S W Lee; H F Gallardo; E Gilboa; C Smith
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Generation of long read-through transcripts in vivo and in vitro by deletion of 3' termination and processing sequences in the human tRNAimet gene.

Authors:  S Adeniyi-Jones; P H Romeo; M Zasloff
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

7.  Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells.

Authors:  T C Lee; B A Sullenger; H F Gallardo; G E Ungers; E Gilboa
Journal:  New Biol       Date:  1992-01

8.  Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.

Authors:  O Heidenreich; F Eckstein
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

9.  Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression.

Authors:  B Dropulić; N H Lin; M A Martin; K T Jeang
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme.

Authors:  J O Ojwang; A Hampel; D J Looney; F Wong-Staal; J Rappaport
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more
  20 in total

1.  RNA aptamers as effective protein antagonists in a multicellular organism.

Authors:  H Shi; B E Hoffman; J T Lis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo.

Authors:  D G Macejak; H Lin; S Webb; J Chase; K Jensen; T C Jarvis; J M Leiden; L Couture
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.

Authors:  T Kuwabara; M Warashina; S Koseki; M Sano; J Ohkawa; K Nakayama; K Taira
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

Authors:  T Kuwabara; M Warashina; T Tanabe; K Tani; S Asano; K Taira
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

5.  Promoter choice affects the potency of HIV-1 specific RNA interference.

Authors:  Daniel Boden; Oliver Pusch; Fredrick Lee; Lynne Tucker; Peter R Shank; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

6.  Ribozymes targeted to stearoyl-ACP delta9 desaturase mRNA produce heritable increases of stearic acid in transgenic maize leaves.

Authors:  A O Merlo; N Cowen; T Delate; B Edington; O Folkerts; N Hopkins; C Lemeiux; T Skokut; K Smith; A Woosley; Y Yang; S Young; M Zwick
Journal:  Plant Cell       Date:  1998-10       Impact factor: 11.277

7.  Intracellular RNA cleavage by the hairpin ribozyme.

Authors:  A A Seyhan; J Amaral; J M Burke
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

8.  Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.

Authors:  S Koseki; T Tanabe; K Tani; S Asano; T Shioda; Y Nagai; T Shimada; J Ohkawa; K Taira
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs.

Authors:  L Gorman; D Suter; V Emerick; D Schümperli; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

10.  An RNA-based transcription activator derived from an inhibitory aptamer.

Authors:  Shengchun Wang; Jason R E Shepard; Hua Shi
Journal:  Nucleic Acids Res       Date:  2010-01-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.